PCMA is the national association representing America’s pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

JOIN PCMA

PCMA believes in offering its members a full range of lobbying, advocacy, and business networking services.
more >>

Lastest News

New Survey: Three in Four Enrollees Oppose Legislation to Change FEHBP
03.10.10

Poll Finds Overwhelming Satisfaction with FEHBP Pharmacy Benefit;
Most Think Bill Would Hurt, Not Help 
(Washington, DC)— Seventy-four percent of those enrolled in the Federal Health Benefits Program (FEHBP) oppose a new effort by Congress to change the program’s prescription drug benefits, according to a new poll released by the Pharmaceutical Care Management Association (PCMA).  
The survey of [...]


More
 
Survey of Federal Employees Regarding FEHBP Drug Benefit
03.10.10
 
PCMA: New GAO Report Highlights the Need for Meaningful Biogenerics Reform
03.01.10


The Lastest

Overhaul to FEHBP would alter free-market cost containment
PCMA SMARTBRIEF | Mar 11, 2010

 

Get more information:
PCMA SMARTBRIEF | Mar 11, 2010

 

Virginia lawmakers reject health insurance mandates
PCMA SMARTBRIEF | Mar 11, 2010

 

Final reform plan may be near
PCMA SMARTBRIEF | Mar 11, 2010

 

Column: Can we expect Congress to meet its health care reform deadline?
PCMA SMARTBRIEF | Mar 11, 2010


Get a daily briefing of the latest news impacting the PBM Industry, health care policy & politics. To sign up for PCMA SmartBrief, CLICK HERE!


PBM Summit

Registration for PCMA’s 2010 PBM Summit is now open and the agenda has been posted to the site.

Keynote speakers will include:

- George Paz, Chairman & CEO, Express Scripts

- David Snow, Chairman & CEO, Medco Health Solutions

- J. Martin Carroll, President & CEO, Boehringer Ingelheim

- Julian Gangolli, President, Allergan

- Bill Marth, Chairman & CEO, Teva

Click here for details or REGISTER NOW!